1. Home
  2. SWTX vs SHC Comparison

SWTX vs SHC Comparison

Compare SWTX & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • SHC
  • Stock Information
  • Founded
  • SWTX 2017
  • SHC 2015
  • Country
  • SWTX United States
  • SHC United States
  • Employees
  • SWTX N/A
  • SHC N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • SHC Medical Specialities
  • Sector
  • SWTX Health Care
  • SHC Health Care
  • Exchange
  • SWTX Nasdaq
  • SHC Nasdaq
  • Market Cap
  • SWTX 3.5B
  • SHC 3.3B
  • IPO Year
  • SWTX 2019
  • SHC 2020
  • Fundamental
  • Price
  • SWTX $46.26
  • SHC $13.13
  • Analyst Decision
  • SWTX Buy
  • SHC Strong Buy
  • Analyst Count
  • SWTX 7
  • SHC 5
  • Target Price
  • SWTX $56.86
  • SHC $15.80
  • AVG Volume (30 Days)
  • SWTX 8.7M
  • SHC 1.2M
  • Earning Date
  • SWTX 05-20-2025
  • SHC 05-01-2025
  • Dividend Yield
  • SWTX N/A
  • SHC N/A
  • EPS Growth
  • SWTX N/A
  • SHC N/A
  • EPS
  • SWTX N/A
  • SHC 0.09
  • Revenue
  • SWTX $191,589,000.00
  • SHC $1,106,788,000.00
  • Revenue This Year
  • SWTX $86.36
  • SHC $3.87
  • Revenue Next Year
  • SWTX $69.02
  • SHC $5.77
  • P/E Ratio
  • SWTX N/A
  • SHC $150.64
  • Revenue Growth
  • SWTX 3417.33
  • SHC 2.78
  • 52 Week Low
  • SWTX $28.21
  • SHC $9.53
  • 52 Week High
  • SWTX $62.00
  • SHC $17.08
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 58.93
  • SHC 69.44
  • Support Level
  • SWTX $46.10
  • SHC $10.68
  • Resistance Level
  • SWTX $46.27
  • SHC $13.37
  • Average True Range (ATR)
  • SWTX 0.90
  • SHC 0.46
  • MACD
  • SWTX 0.58
  • SHC 0.27
  • Stochastic Oscillator
  • SWTX 99.46
  • SHC 92.15

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Share on Social Networks: